Insulin Resistance, Defective Insulin-Mediated Fatty Acid Suppression, and Coronary Artery Calcification in Subjects With and Without Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess insulin action on peripheral glucose utilization and nonesterified fatty acid (NEFA) suppression as a predictor of coronary artery calcification (CAC) in patients with type 1 diabetes and nondiabetic controls. RESEARCH DESIGN AND METHODS: Insulin action was measured by a three-stage hyperinsulinemic-euglycemic clamp (4, 8, and 40 mU/m2/min) in 87 subjects from the Coronary Artery Calcification in Type 1 Diabetes cohort (40 diabetic, 47 nondiabetic; mean age 45 ± 8 years; 55% female). RESULTS: Peripheral glucose utilization was lower in subjects with type 1 diabetes compared with nondiabetic controls: glucose infusion rate (mg/kg FFM/min) = 6.19 ± 0.72 vs. 12.71 ± 0.66, mean ± SE, P < 0.0001, after adjustment for age, sex, BMI, fasting glucose, and final clamp glucose and insulin. Insulin-induced NEFA suppression was also lower in type 1 diabetic compared with nondiabetic subjects: NEFA levels (μM) during 8 mU/m2/min insulin infusion = 370 ± 27 vs. 185 ± 25, P < 0.0001, after adjustment for age, sex, BMI, fasting glucose, and time point insulin. Lower glucose utilization and higher NEFA levels, correlated with CAC volume (r = −0.42, P < 0.0001 and r = 0.41, P < 0.0001, respectively) and predicted the presence of CAC (odds ratio [OR] = 0.45, 95% CI = 0.22–0.93, P = 0.03; OR = 2.4, 95% CI = 1.08–5.32, P = 0.032, respectively). Insulin resistance did not correlate with GHb or continuous glucose monitoring parameters. CONCLUSIONS: Type 1 diabetic patients are insulin resistant compared with nondiabetic subjects, and the degree of resistance is not related to current glycemic control. Insulin resistance predicts the extent of coronary artery calcification and may contribute to the increased risk of cardiovascular disease in patients with type 1 diabetes as well as subjects without diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Excess adiposity was associated with inadequate glycemic control in patients with T1D in the T1D Exchange study cohort.34”
From Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Adults with Type 1 Diabetes (2025) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Quantification of coronary artery calcium using ultrafast computed tomography
Agatston, A. S., Janowitz, W. R., Hildner, F. J., Zusmer, N. R., Viamonte, M., & Detrano, R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90282-t · Cited by 7,786 · cited 1×
“Calcium volume scores (CVS) were calculated using the volumetric method, which is based on isotropic interpolation, as previously described (40,41).”
MethodGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 2×
“5 hours using the method of DeFronzo et al (39).”
MethodInfluentialIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760 · cited 1×
“Insulin resistance has been strongly implicated as a cardiovascular risk factor in the general population(17-25).”
Background(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815
Insulin Sensitivity and Atherosclerosis
Howard, G., O’Leary, D. H., Zaccaro, D., Haffner, S., Rewers, M., Hamman, R., Selby, J. V., Saad, M. F., Savage, P., & Bergman, R. (1996) · Circulation · doi:10.1161/01.cir.93.10.1809 · Cited by 729
Self-citationKrolewski, A. S., Kosinski, E. J., Warram, J. H., Stevens Leland, O., Busick, E. J., Cader Asmal, A., Rand, L. I., Christlieb, A. R., Bradley, R. F., & Kahn, C. R. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91086-1 · Cited by 654 · cited 2×
“9mmol/L), (3) Hyperglycemia, percentage of glucose values >180mg/dl (10mmol/L), and (4)Glycemic variability within days, overall standard deviation (SDT), the standard deviation of all glucose values.”
Background
Cited by
Items 201–234 of 234
Diabetes and coronary circulation: From pathology to imaging
Henein, M. Y., Vancheri, S., & Vancheri, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817428-9.00008-5 · Cited by 1
Heparin Effects on Serum Gonadotropins
Kohn, S. A., Fought, A. J., Kuhn, K., Sloggett, K. J., Bradford, A. P., Santoro, N. F., & Schauer, I. E. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab178 · Cited by 1
Self-citationAspectos clínicos y diagnósticos de la diabetes infantil
Louvigné, M., Decrequy, A., Donzeau, A., Bouhours‐Nouet, N., & Coutant, R. (2018) · EMC - Pediatría · doi:10.1016/s1245-1789(17)88072-0 · Cited by 8
Double Diabetes: Modern Challenge
As, A., Moscow, R. F., Pashkova, E. Y., & Рамазанович, Г. В. (2024) · Doctor Ru · doi:10.31550/1727-2378-2024-23-4-7-14 · Cited by 1
Excess mortality and cardiovascular disease risk in type 1 diabetes
SNAITH, J. R., Holmes-Walker, D. J., Girgis, C. M., & Greenfield, J. R. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33050-2 · Cited by 1
SNAITH, J. R., Holmes-Walker, D. J., & Greenfield, J. R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa383 · Cited by 1
Lithovius, R. (2015) · Työväentutkimus Vuosikirja
SENSORY NEURON INSULIN SIGNALING AND ITS ROLE IN DIABETIC NEUROPATHY
Grote, C. W. (2013) · KU ScholarWorks (The University of Kansas)
Aspectos clínicos y diagnósticos de la diabetes infantil
Bouhours‐Nouet, N., & Coutant, R. (2011) · EMC - Pediatría · doi:10.1016/s1245-1789(11)71180-5 · Cited by 2
Biomarkers for evaluating renal function decline in diabetes: where are we now?
Snell‐Bergeon, J. K. (2012) · Diabetes Management · doi:10.2217/dmt.12.50
Self-citationLukito, A. A., Widyasanto, A., Yulianti, T., Muljadi, R., Wijaya, A., Kabo, P., & Bakri, S. (2011) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v3i3.149
Metabolic responses to physical activity in subjects with type 1 diabetes
Brugnara, L. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Monitoring of vascular health in children at risk for atherosclerosis.
Harrington, J. (2014) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Esteves, J. V. D. C. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2017.tde-17052017-164705
Running title: Peripheral Insulin Delivery and Hypoglycemia
Gregory, J. M., Kraft, G., Scott, M. F., Neal, D. W., Farmer, B., Hastings, J. R., Allen, E. J., Donahue, E. P., Rivera, N., Winnick, J. J., et al. (2015)
Ena, J., & Gómez‐Huelgas, R. (2019) · Revista Clínica Española · doi:10.1016/j.rce.2019.09.001
Ena, J., & Gómez‐Huelgas, R. (2020) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2019.09.011
Kahkoska, A. R. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/pmkd-k264
SNAITH, J. R., Olsen, N., & Greenfield, J. R. (2023) · medRxiv · doi:10.1101/2023.11.20.23298602
Analysis of insulin resistance levels in patients with type 1 diabetes
Marjanović, A., Marković, M., & Milicic, T. J. (2023) · Medicinski podmladak · doi:10.5937/mp74-40461
Treatment of Obesity in Individuals with Type 1 Diabetes
Almehthel, M. S., & Alshehri, A. (2024) · Canadian Diabetes & Endocrinology Today · doi:10.58931/cdet.2024.2332
Uruska, A. A., Miętkiewska-Dolecka, M., Grzelka‐Woźniak, A., Flotyńska, J., Saldanha, S., Rohatgi, A. K., & Zozulińska‐Ziółkiewicz, D. (2025) · Endocrine Connections · doi:10.1530/ec-24-0704
Garau, M., Lorenzi, R. D., Aída, E., Barreneche, L., Bruno, L., Costa, M., Airaudo, C., Álvarez, T., Hernández, E. S., Melone, I., et al. (2025) · Revista Uruguaya de Medicina Interna · doi:10.26445/10.01.11
Lipid metabolism in type 1 diabetes initiation and progression to vascular disease
Borowsky, N. S., Michel, R., Hirani, K., & Vendrame, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19116-9.00028-2
Additional file 1 of Association of hyperuricemia combined with sarcopenia on ASCVD risk
Nie, G., Wan, J., Jiang, L., Zhang, M., Yan, F., & Peng, W. (2023) · Figshare · doi:10.6084/m9.figshare.23590690
Linn, W., Persson, M., Rathsman, B., Ludvigsson, J., Lind, M., Andersson Franko, M., & Nyström, T. (2023) · Figshare · doi:10.6084/m9.figshare.22623472
Xin, Y., Zhang, J., Fan, Y., & Wang, C. (2021) · Figshare · doi:10.6084/m9.figshare.14992949
Type 1 Diabetes: Pathophysiology and Treatment Considerations for Cardiovascular Risk and Disease
Tommerdahl, K. L., & Bjornstad, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-87862-3.00005-7
Why glycemic control remains suboptimal in type 1 diabetes in the era of advanced technologies?
Joubert, M. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101763
Ni, H., SNAITH, J. R., & Greenfield, J. R. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.04.001
Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes
Buros‐Stein, A., PAULEY, M. E., & Snell‐Bergeon, J. K. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.04.003
Self-citationCortes, J. A. P., Narongkiatikhun, P., Snethlage, C. M. F., Castillo, D. D., Tommerdahl, K., Nadeau, K., & Bjornstad, P. (2026) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/j.ecl.2026.04.008
Hasbullah, H., Dewi, F. N., Faridah, D. N., Indrasti, D., Prabandari, S. A., Andarwulan, N., & Średnicka-Tober, D. (2026) · Nutrients · doi:10.3390/nu18162686
Vascular calcification: pathogenic mechanisms, signaling crosstalk and translational therapeutics
Hua, R., Qiao, B., Liu, X., Jiang, B., Wu, J., Zhang, C., Liu, H., Wang, B., Wei, S., & Chen, Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02884-1
Metadata
- Authors
- Schauer, I. E., Snell-Bergeon, J. K., Bergman, B. C., Maahs, D. M., Kretowski, A., Eckel, R. H., & Rewers, M.
- Affiliations
- University of Colorado Anschutz (US)
- Barbara Davis Center for Childhood Diabetes, School of Medicine, University of Colorado Denver, Aurora, Colorado.
- Corresponding author
- Schauer, Irene E.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-10-26
- Volume
- 60
- Issue
- 1
- Pages
- 306-314
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3012187
- OpenAlex
- W2140420590
- Cited by
- 230
- References
- 50
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 13 · 2023: 13 · 2022: 11 · 2021: 23 · 2020: 13 · 2019: 15 · 2018: 11 · 2017: 19 · 2016: 9 · 2015: 24 · 2014: 17 · 2013: 13 · 2012: 17
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (BIRCWH K12 Program, P30 DK)
- National Heart, Lung, and Blood Institute (R01HL113029, HL61753, R01HL61753, R01HL061753, R01HL079611)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057516, P30 DK 57516)
- National Center for Research Resources (M01RR000051)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- insulin resistance, type 1 diabetes, coronary artery calcification, free fatty acids, peripheral glucose utilization, hyperinsulinemic-euglycemic clamp, cardiovascular risk, glycemic control, HbA1c, continuous glucose monitoring, atherosclerosis, diabetic cardiomyopathy, dyslipidemia, dyslipoproteinemia
- MeSH terms
- Abdomen, Adipose Tissue, Adult, Blood Glucose, Body Composition, Calcium, Coronary Vessels, Diabetes Mellitus, Type 1, Diabetic Angiopathies, Environmental Monitoring, Fatty Acids, Fatty Acids, Nonesterified, Female, Glycerol, Humans, Hyperinsulinism, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Reference Values, Spleen, Tomography, X-Ray Computed, Glucose Clamp Technique, Cohort Studies, Absorptiometry, Photon, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.